PONIARD PHARMACEUTICALS, INC. - FORM 10-K - EX-32.2 - SECTION 906 CFO CERTIFICATION - March 30, 2011

Attached files

file filename
10-K - ANNUAL REPORT ON FORM 10-K - PONIARD PHARMACEUTICALS, INC.d10k.htm
EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - PONIARD PHARMACEUTICALS, INC.dex231.htm
EX-32.1 - SECTION 906 CEO CERTIFICATION - PONIARD PHARMACEUTICALS, INC.dex321.htm
EX-31.2 - SECTION 302 CFO CERTIFICATION - PONIARD PHARMACEUTICALS, INC.dex312.htm
EX-31.1 - SECTION 302 CEO CERTIFICATION - PONIARD PHARMACEUTICALS, INC.dex311.htm

Exhibit 32.2

CERTIFICATION OF ANNUAL REPORT

I, Michael K. Jackson, Interim Chief Financial Officer of Poniard Pharmaceuticals, Inc. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:

 

  1. the Annual Report on Form 10-K for the Company for the year ended December 31, 2010 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (12 U.S.C. 78m or 78o(d)); and

 

  2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: March 30, 2011

     By:    /S/ MICHAEL K. JACKSON             
     

Michael K. Jackson

Interim Chief Financial Officer

PONIARD PHARMACEUTICALS, INC. Reports

Also read